Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Kymera Therapeutics, Inc. (KYMR) had Debt to Capital Ratio of 0.00 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$11.48M |
|
$-76.61M |
|
-- |
|
$11.48M |
|
$96.03M |
|
$-84.56M |
|
$7.94M |
|
$-76.61M |
|
$-76.61M |
|
$-76.61M |
|
$-76.61M |
|
$-76.61M |
|
$-76.61M |
|
$-84.56M |
|
$-84.59M |
|
80.45M |
|
80.45M |
|
$-0.95 |
|
$-0.95 |
|
| Balance Sheet Financials | |
$728.33M |
|
$48.57M |
|
$402.74M |
|
$1.13B |
|
$87.54M |
|
$2.21M |
|
$72.05M |
|
$159.59M |
|
$971.48M |
|
$971.48M |
|
$971.48M |
|
70.56M |
|
| Cash Flow Statement Financials | |
$-139.03M |
|
$108.64M |
|
$245.98M |
|
$126.05M |
|
$341.64M |
|
$215.59M |
|
$29.65M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.32 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
0.00 |
0.00 |
|
100.00% |
|
-736.82% |
|
-736.82% |
|
-- |
|
-667.60% |
|
-667.60% |
|
$-140.20M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
0.29 |
|
313.70 |
|
-7.89% |
|
-7.89% |
|
-6.77% |
|
-7.87% |
|
$13.77 |
|
$-1.74 |
|
$-1.73 |
|